Add Company
Join Now

ChemDiv Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • ChemDiv's estimated annual revenue is currently $6.1M per year.(i)
  • ChemDiv's estimated revenue per employee is $91,800

Employee Data

  • ChemDiv has 66 Employees.(i)
  • ChemDiv grew their employee count by 6% last year.

ChemDiv's People

NameTitleEmail/Phone
1
VP Drug DiscoveryReveal Email/Phone
2
Director, Business DevelopmentReveal Email/Phone
3
Research DirectorReveal Email/Phone
4
Executive DirectorReveal Email/Phone
5
Business Development ManagerReveal Email/Phone
6
Manager, Customer Support GroupReveal Email/Phone
7
Business DevelopmentReveal Email/Phone
8
Senior Regional Business Development Director for Integrated Drug Discovery CRO ServicesReveal Email/Phone
9
BD ExecutiveReveal Email/Phone
10
Sr. Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24M21410%N/AN/A
#2
$4.8M52-4%N/AN/A
#3
$2.9M369%N/AN/A
#4
$22.4M2005%N/AN/A
#5
$1.7M249%N/AN/A
#6
$10.1M99-1%N/AN/A
#7
$5.8M639%N/AN/A
#8
$3.2M39N/AN/AN/A
#9
$5.8M63-3%N/AN/A
#10
$0.8M13N/AN/AN/A
Add Company

What Is ChemDiv?

ChemDiv, a fully Integrated Target-to-Market Contract Research Organization (CRO) headquartered in San Diego, CA USA. ChemDiv provides integrated drug discovery and early clinical development deliverables by extracting added value from potential therapeutic candidates via rapid, streamlined outcomes and effective use of capital. - 25 years experience and 2500 customers worldwide - Premium R&D CRO based in USA with global reach - Seasoned project managers - Extensive Academic partnerships - Flexible business models - Competitive pricing options - Industry's largest ever-greening stock compound inventory - Ongoing investments in novel proprietary chemistry and discovery platforms One of the oldest CROs in the industry, ChemDiv provides Integrated Discovery outSourceâ„¢ solutions that cover the complete range of disciplines needed to bring new drugs for treatment of CNS, oncology, inflammation, metabolic and infectious diseases from target to candidate and through clinical Proof of Concept to the market. ChemDiv champions collaborative development models with co-investors to rescue under-exploited R&D assets for pharmaceutical and biotech partners.

keywords:N/A

N/A

Total Funding

66

Number of Employees

$6.1M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.5M6625%$12M
#2
$8.3M66N/AN/A
#3
$8.6M66N/AN/A
#4
$16.6M66N/AN/A
#5
$5.1M6620%$113.6M